New Microbiome Flagship Translational Program

TRI has already established a Diagnostic Imaging Program as the first of its Flagship Translational Programs.  The Program currently has 17 projects in various stages of development.  Some are well established and undertaking clinical studies, while others are in the planning phase and awaiting ethics approval.  Each addresses a clinical question with a potentially marketable solution.

The reason behind establishing a Flagship Translational Program is to attract resources that will benefit the individual projects.  These resources include funding, expertise, industry collaborators and technologies.  TRI Caucus is currently discussing the possibility of another Flagship Translational Program on the Microbiome. 

At a meeting in March 2016, Professor Josephine Forbes, Chair of the TRI Caucus, and Professor Gerald Holtmann hosted a discussion featuring presentations from TRI-based researchers and collaborators on projects that involve the Microbiome.  

These include:

  • Dr Marcus Gray, from the Centre for Advanced Imaging, who is working with Professor Gerald Holtmann to explore whether the microbiome regulates inflammation in the gut and brain;
  • Professor Mike McGuckin who is interested in the role of secreted and cell surface mucin glycoproteins in host defense from infection and inflammation;
  • Professor Ian Frazer who is interested in the role the skin microbiome plays in developing and activating the immune system;
  • Dr Ashok Raj on Liver and the microbiome;
  • Dr Katrina Campbell on dietary pre/probiotics to improve kidney function; and
  • Dr Paraic O’Cuiv on Australia’s contribution to the international microbiome consortium. 

> More information about this potential TRI flagship program will be available soon. 

What is microbiome? the microorganisms in a particular environment, including the body or a part of the body.